Taking the most popular type of antidepressants during pregnancy does not increase the risk of stillbirth or newborn death, according to the latest sweeping study in a string of investigations probing the safety of pregnant women taking the drugs.
Researchers analyzed data from more than 1.6 million women in Nordic countries, including nearly 30,000 women who had filled a prescription for a selective serotonin reuptake inhibitor (SSRI) while pregnant.
Women who took an SSRI did have higher rates of stillbirth and infant death than those who did not. "However," study co-author Dr. Olof Stephansson, a clinical epidemiologist with Karolinska University Hospital in Sweden told HuffPost, "this was because of an increased proportion of smokers, older [maternal] age, diabetes and hypertensive disease."
"The risk increase," he explained, "was attributed to [those] factors and not the medication."
The data used in the study was obtained from prescription registries in Denmark, Finland, Iceland, Norway and Sweden, as well as from patient and birth registries in those countries. The findings were published in the Journal of the American Medical Association this week and funded, in part, by the Swedish Pharmacy Company.
"This data is some of the best in the world [for] doing population-based research," said Dr. Katherine Moore, an assistant professor of psychiatry with the Mayo Clinic, who did not work on the study. "It integrates data from multiple sources: out-patient and in-patient, pharmacy records. This study offers additional evidence supporting the safety of SSRI use in pregnancy."
A 2009 joint report from the American College of Obstetricians and Gynecologists and American Psychiatric Association found that up to 23 percent of women have at least one depressive episode while pregnant. Women with mild symptoms should consider not using SSRIs during pregnancy, that report recommended, but women with severe depression should continue taking medication as untreated severe depression carries potential risks for both mom and baby.
But not all recent research supports the safety of SSRIs during pregnancy. A widely covered study published in November in the journal Human Reproduction found that pregnant women who take SSRIs may have a greater risk of pregnancy complications, including birth defects, preterm birth and miscarriage.
Dr. Adam Urato, chairman of obstetrics and gynecology at MetroWest Medical Center in Massachusetts and an author on that study, expressed some concerns about the latest research.
"The [JAMA] study looked at information on dispensed drugs, not ingested drugs and these numbers are often quite different," he said in an email to The Huffington Post. "When exposure information is inexact … the result is often that we do not find evidence of harm from a drug," Urato added.
A woman might get misclassified as taking an SSRI and having a good outcome, but actually belonged in the 'not taking an SSRI' group, he said.
Though the authors of the new study found no significant link between SSRI use during pregnancy and risk of stillbirth or newborn death, they stressed that decisions about treatment options must take into account other possible outcomes.
"Previous studies have found an increased risk for congenital cardiac malformations for Paroxetine [known by trade names like Paxil] and a modest risk increase for persistent pulmonary hypertension among newborns," Stephansson said.
"This is the most individualized medicine we can do," agreed Moore. "These risk-benefit discussions are so crucial for each patient and their partner -- if a partner's involved."
"For mild symptoms, we should absolutely consider non-pharmacologic treatments first, to avoid any risk to the fetus," she said. "But when medication is suggested by moderate to severe symptoms of depression, providers and patients can feel confident about the safety of [SSRIs]."
When patients have moderate to severe symptoms, however, "providers and patients can feel confident about the safety of [SSRIs]," said Moore.
Our 2024 Coverage Needs You
It's Another Trump-Biden Showdown — And We Need Your Help
The Future Of Democracy Is At Stake
Our 2024 Coverage Needs You
Your Loyalty Means The World To Us
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
The 2024 election is heating up, and women's rights, health care, voting rights, and the very future of democracy are all at stake. Donald Trump will face Joe Biden in the most consequential vote of our time. And HuffPost will be there, covering every twist and turn. America's future hangs in the balance. Would you consider contributing to support our journalism and keep it free for all during this critical season?
HuffPost believes news should be accessible to everyone, regardless of their ability to pay for it. We rely on readers like you to help fund our work. Any contribution you can make — even as little as $2 — goes directly toward supporting the impactful journalism that we will continue to produce this year. Thank you for being part of our story.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
It's official: Donald Trump will face Joe Biden this fall in the presidential election. As we face the most consequential presidential election of our time, HuffPost is committed to bringing you up-to-date, accurate news about the 2024 race. While other outlets have retreated behind paywalls, you can trust our news will stay free.
But we can't do it without your help. Reader funding is one of the key ways we support our newsroom. Would you consider making a donation to help fund our news during this critical time? Your contributions are vital to supporting a free press.
Contribute as little as $2 to keep our journalism free and accessible to all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. Would you consider becoming a regular HuffPost contributor?
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. If circumstances have changed since you last contributed, we hope you'll consider contributing to HuffPost once more.
Support HuffPostAlready contributed? Log in to hide these messages.